Clinical Trial Update: Treatment of Adult ALL With an MRD-directed Programme. [Phase 2]

View source ↗

Summary

Phase 2 trial by the Northern Italy Leukemia Group evaluating an MRD-directed treatment program in adults with acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Northern Italy Leukemia Group | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED